At the news
? NEUTRALIMPACT 2/10 8-K filed Nov 9, 2026 at 16:16 ET
Stryker announced the nomination of James E. Davis, Chairman, CEO and President of Quest Diagnostics, to its board of directors, effective January 1, 2027. The board was expanded from 11 to 12 members to accommodate his election. This is a routine board addition with no financial terms disclosed.
- Board of Directors increased authorized directors from 11 to 12 and elected James E. Davis to fill the vacancy
- Mr. Davis's election becomes effective January 1, 2027
- Mr. Davis is Chairman, CEO and President of Quest Diagnostics
- Mr. Davis will be compensated consistent with other non-employee directors as described in the 2026 proxy statement
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access